Efficacy of ursodeoxycholic acid administration as adjuvant therapy together with alfa-interferon for chronic hepatitis C.

被引：0
|
作者：
Fabbri, C [1 ]
Mazzella, G [1 ]
Marchetto, S [1 ]
Pezzoli, A [1 ]
Fusaroli, P [1 ]
Accogli, E [1 ]
Azzaroli, F [1 ]
Mazzeo, C [1 ]
Jaboli, F [1 ]
Roda, E [1 ]
机构：
[1] UNIV BOLOGNA, DEPT INTERNAL MED & GASTROENTEROL, BOLOGNA, ITALY
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1261 / A1261
页数：1
相关论文
共 50 条
  • [31] Safety, efficacy and pharmacokinetics of interferon alfa-2B and ribavirin in children with chronic hepatitis C.
    Bunn, S
    Kelly, D
    Murray, KF
    Shelton, M
    Olson, A
    Mieli-Vergani, G
    Zambas, D
    Gupta, SK
    Glue, P
    HEPATOLOGY, 2000, 32 (04) : 350A - 350A
  • [32] Ursodeoxycholic acid for treatment of chronic hepatitis C: an 'interferon sparing' effect
    Lanzini, A
    Pigozzi, MG
    Distefano, L
    Reggiani, A
    Lorini, GP
    Sorbara, R
    De Tavonatti, MG
    Bettini, L
    Montani, G
    Baisini, O
    Lanzarotto, F
    Quatrocchi, D
    Cominotti, A
    Favret, M
    BILE ACIDS IN HEPATOBILIARY DISEASE, 2000, 110B : 159 - 164
  • [33] Histological response of interferon therapy in chronic hepatitis C.
    Segawa, T
    Moriyama, M
    Shibahara, N
    Kaneko, M
    Suzuki, K
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Sugitani, M
    Suzuki, K
    Uchida, T
    Shikata, T
    GASTROENTEROLOGY, 1997, 112 (04) : A1378 - A1378
  • [34] Breakthrough and interferon dose in the therapy of chronic hepatitis C.
    Bellati, G
    Roffi, L
    Colloredo, G
    DAcquino, M
    Ricci, A
    Redaelli, A
    Tempini, S
    Bellobuono, A
    Bonino, F
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P97 - P97
  • [35] Predictive factors of sustained response to interferon-alfa-2b therapy in chronic hepatitis C.
    Kuziemski, A
    Halota, W
    FASEB JOURNAL, 1998, 12 (05): : A1047 - A1047
  • [36] ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS
    DICESARE, E
    PREVITI, M
    RUSSO, F
    SARDO, MA
    INGEMI, MC
    SCOGLIO, R
    CUCINOTTA, D
    RAIMONDO, G
    HEPATOLOGY, 1994, 20 (04) : A165 - A165
  • [37] EFFECT OF LYMPHOBLASTOID ALFA-INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C HAVING DIFFERENT GENOTYPIC SUBTYPE OF HEPATITIS-C VIRUS
    CHAYAMA, K
    TSUBOTA, A
    ARASE, Y
    SAITOH, S
    IKEDA, K
    MATSUMOTO, T
    SAKAI, Y
    KOBAYASHI, M
    MORINAGA, T
    KUMADA, H
    GASTROENTEROLOGIA JAPONICA, 1993, 28 : 45 - 47
  • [38] Combined effects of ursodeoxycholic acid and phlebotomy on patients with chronic hepatitis C.
    Arao, M
    Kato, S
    Hayashi, H
    Wakusawa, S
    Sanae, F
    Takikawa, T
    Ikeda, R
    Yano, M
    Yoshioka, K
    HEPATOLOGY, 1998, 28 (04) : 711A - 711A
  • [39] Effect of ursodeoxycholic acid (UDCA) on autoimmune associated chronic hepatitis C.
    Nakamura, K
    Yokohama, S
    Tamori, K
    Sato, Y
    Hasegawa, T
    Yoneda, M
    Makino, I
    GASTROENTEROLOGY, 1997, 112 (04) : A1344 - A1344
  • [40] Treatment of children with chronic hepatitis B unresponsive to alfa-interferon with famciclovir: Preliminary report
    Naveh, Y
    Lapidot, A
    Berkowitz, D
    Satinger, Y
    Ben-Porath, E
    HEPATOLOGY, 1998, 28 (04) : 215A - 215A
12345